The Pharmaceutical Journal,
September 16, 2000

Back issues

Comment

An Onlooker's Notebook   382

• Achieving grades
• Sinister slant
• Betel and the brain

Leading Articles   383

• Pharmacy leaves the crossroads

News   384-386

• Electronic prescribing and medicines management pilots next year 384-385
• Reserved welcome for pharmacy plan from PSNC and NPA 385
• Department readvertises for a chief pharmacist 385
• Moss's new customer satisfaction standards 385
• One in four Manchester pharmacies issues emergency contraception 386
• Fuel crisis threatens drug supplies 386
• ICCA launched at Pharmacy Live 386
• Call for specialist pharmacists for residential homes386

Clinical Pharmacy   387-389

• Updated "yellow card" launched 387
• NICE issues guidance on asthma inhalers 387
• Half of all . yellow card. reports on rofecoxib are for gastrointestinal effects 387
• New proton pump inhibitor licensed for "on demand" use 388
• Parkinson's drug for restless legs syndrome? 388
• "Targeted" drug for breast cancer launched 389
• Benefits of tamoxifen may be outweighed by risks in some patients, researchers say 389

The Society   390-392

• Guidance on counter prescribing 390-392

Broad Spectrum   393

• The secret Society (J. Wilson) 393

Letters to the Editor   394-396

• The Society
  • Separation of functions 394
  • Leading rule? 394
  • Be there when it matters 394
  • Anathematical state of affairs394
• The Conference - Spiritual relection 394
• The profession - Not happy 395
• Pharmacy in a new age - A long way to go 395
• The Journal - Position of editor 395
• Veterinary pharmacy - From the horse's mouth 395
• Paediatrics - Disagreements 396
• Pharmacy overseas - New Zealand pharmacies 396

Conference   397-428

• Keynote speeches:
  • Plan sets out how pharmacy can build a future for itself, says Minister 397-400
  • "A watershed for the profession," says the President 400
• Practice research award lecture: The many faces of prescribing 401
• News and notes:
  • Society redesigns its website 402
  • BPC moves to Glasgow in 2001 402
  • Launch of Society guidance on respiratory disease and mental health 403
  • Presentation of Glaxo Wellcome international achievement award 403
  • Complementary therapy fact sheet launched 403
  • Facts and figures 403
• Pharmacy practice research review 406-410
• Science Chairman's address: From genomics to the clinic: the challenge for molecular science? (M. Davies) 411-415

Products   429

• Herceptin infusion 429
• Elleste Duet Conti tablets 429
• Kogenate Bayer injection 429
• Pabrinex 429
• Calcium chloride injection 429
• Discontinued 429
• Prochlorperazine tablets 429
• Gelofusine 429

Notice-Board   430

• Diary 430
• Future events 430
• Official notices 430
• Drug tariff update 430

Front Cover Picture

Our front cover illustration is a collage of scenes from the British Pharmaceutical Conference which took place in Birmingham from September 10. 13. We begin our comprehensive coverage of the Conference this week (p397).

Pharmacy and the NHS national plan

In a speech at the British Pharmaceutical Conference, Lord Hunt (Parliamentary Under-Secretary of State for Health) set out the details of how the national plan for the National Health Service in England will apply to pharmacy (p397). The Society. s President (Mrs Christine Glover) hailed Lord Hunt. s announcement as a "watershed" for the profession (p400). Leading article (p383).

Respiratory and mental health guidance

The Royal Pharmaceutical Society launched guidance on mental health, asthma and chronic obstructive pulmonary disease at the Conference (p403). Guidance summaries (p390).

Practice research

A review of Conference practice research begins on p406.

Molecular science

The Conference Science Chairman. s address on challenges for molecular science is published this week (pp411 - 415).